Skip to content

The Value of a Simple Tool for the Early Detection of Decompensated Heart Failure in People Over 55 on Réunion Island: A Preliminary Study in Hospitals (DEPIST'IC-RUN)

The Value of a Simple Tool for the Early Detection of Decompensated Heart Failure in People Over 55 on Réunion Island: A Preliminary Study in Hospitals (DEPIST'IC-RUN)

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07673562
Acronym
DEPIST'IC-RUN
Enrollment
300
Registered
2026-06-29
Start date
2026-08-12
Completion date
2027-02-01
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

Decompensated heart failure, early detection, questionnaire

Brief summary

The goal of this study is to assess the discriminatory power of a previously developed tool for detecting decompensated heart failure-which includes, in particular, clinical signs-in a population of patients hospitalized in cardiology units in Réunion. The main question it aims to answer is : Would a simple and rapid screening tool for decompensated heart failure help identify a high probability of this condition in a population hospitalized in a cardiology unit in Réunion? This study includes patients aged 55 and older, who reside in Réunion, who were admitted on an unscheduled basis to the cardiology department at the Réunion University Hospital or the Ouest Réunion Hospital, for any reason (whether as an inpatient or in the intensive care unit) The study is conducted in two phases: Phase 1: Development of the new e-DELPHI consensus-based screening tool Phase 2: Administration of the Déspist'IC-Run early detection tool for decompensated heart failure and performance of the gold standard cardiology examination (RIPH3)

Detailed description

This is a preliminary, cross-sectional "diagnostic" ("screening") study (to assess validity relative to the gold standard test), conducted at two centers, evaluating a questionnaire that does not alter the patient's standard of care (prospective data collection).

Interventions

DIAGNOSTIC_TESTEarly Detection Questionnaire

Questionnaire for the Early Detection of Heart Failure

Sponsors

Centre Hospitalier Universitaire de la Réunion
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
55 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients: * Aged 55 and older * Admitted on an unscheduled basis to the cardiology department at the CHU (North and South campuses) and the CHOR for any reason (in general wards or intensive care) * Residents of Réunion * Able to read and write French * Enrolled in a social security program * Willing to participate in the study

Exclusion criteria

Patients: * Who cannot communicate in French * For whom it is impossible to administer the questionnaire * For whom the ETT and/or cardiology consultation are impossible * Who are under guardianship, conservatorship, or judicial protection

Design outcomes

Primary

MeasureTime frameDescription
Estimating the discriminant validity of a tool for detecting decompensated heart failure"From enrollment to the end of the study, at 6 monthThe probability of having decompensated heart failure, as determined by a screening tool in the form of a questionnaire, will be calculated using the equation of a logistic regression model that explains the observed status (dependent variable) as determined by the gold standard test. The gold standard test for establishing a definitive diagnosis of decompensated heart failure will combine three tests: a clinical examination by a cardiologist, a transthoracic Doppler echocardiogram (TTE), and an electrocardiogram.

Secondary

MeasureTime frameDescription
Describe the operational phases involved in developing the screening tool.From enrolment to the end of the study, at 6 monthThe detailed description of the tool's development phase is a task that complements statistical modeling (of the tool's development) and is purely epidemiological in nature.
Describe the sociodemographic and clinical characteristics, as well as the lifestyle habits, of the study population.From enrollment to the end of the study at 6 monthsThe following characteristics are collected: age, sex, socioeconomic status, residential area (north, south, west, east); cardiovascular risk factors (hypertension, diabetes, dyslipidemia, known heart disease, history of myocardial infarction, end-stage renal disease requiring dialysis); lifestyle factors (Body Mass Index (kg/m²), physical activity \> 30 min at least 3 times/week, current smoking, alcohol consumption \> 3 drinks/day).
Compare the sociodemographic and medical characteristics of this population of patients hospitalized in cardiology with those of other populations of patients with heart failure seen in private practices-whether in cardiology or general practiceFrom enrollment to the end of the study at 6 monthSocio-demographic data (age, sex, residential area) and clinical data (cardiovascular history) for the population with heart failure in Réunion, obtained from the SNDS, will be compared with those of the sample in this study

Contacts

CONTACTJérôme CORRE, Dr
jerome.corre@chu-reunion.fr+262 262 90 05 52

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 30, 2026